TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading.

MLA

Schallenberg, Simon, et al. “TTF-1 Status in Early-Stage Lung Adenocarcinoma Is an Independent Predictor of Relapse and Survival Superior to Tumor Grading.” European Journal of Cancer (Oxford, England : 1990), vol. 197, Jan. 2024, p. 113474. EBSCOhost, https://doi.org/10.1016/j.ejca.2023.113474.

APA

Schallenberg, S., Dernbach, G., Dragomir, M. P., Schlachtenberger, G., Boschung, K., Friedrich, C., Standvoss, K., Ruff, L., Anders, P., Grohé, C., Randerath, W., Merkelbach-Bruse, S., Quaas, A., Heldwein, M., Keilholz, U., Hekmat, J. K., Rückert, C., Büttner, R., Horst, D., … Frost, N. (2024). TTF-1 status in early-stage lung adenocarcinoma is an independent predictor of relapse and survival superior to tumor grading. European Journal of Cancer (Oxford, England : 1990), 197, 113474. https://doi.org/10.1016/j.ejca.2023.113474

Chicago

Schallenberg, Simon, Gabriel Dernbach, Mihnea P Dragomir, Georg Schlachtenberger, Kyrill Boschung, Corinna Friedrich, Kai Standvoss, et al. 2024. “TTF-1 Status in Early-Stage Lung Adenocarcinoma Is an Independent Predictor of Relapse and Survival Superior to Tumor Grading.” European Journal of Cancer (Oxford, England : 1990) 197 (January): 113474. doi:10.1016/j.ejca.2023.113474.